Paydak H, Kall J G, Burke M C, Rubenstein D, Kopp D E, Verdino R J, Wilber D J
Clinical Electrophysiology Laboratories, Section of Cardiology, University of Chicago, Ill, USA.
Circulation. 1998 Jul 28;98(4):315-22. doi: 10.1161/01.cir.98.4.315.
The occurrence of atrial fibrillation after ablation of type I atrial flutter remains an important clinical problem. To gain further insight into the pathogenesis and significance of postablation atrial fibrillation, we examined the time to onset, determinants, and clinical course of atrial fibrillation after ablation of type I flutter in a large patient cohort.
Of 110 consecutive patients with ablation of type I atrial flutter, atrial fibrillation was documented in 28 (25%) during a mean follow-up of 20.1+/-9.2 months (cumulative probability of 12% at 1 month, 23% at 1 year, and 30% at 2 years). Among 17 clinical and procedural variables, only a history of spontaneous atrial fibrillation (relative risk 3.9, 95% confidence intervals 1.8 to 8.8, P=0.001) and left ventricular ejection fraction <50% (relative risk 3.8, 95% confidence intervals 1.7 to 8.5, P=0.001) were significant and independent predictors of subsequent atrial fibrillation. The presence of both these characteristics identified a high-risk group with a 74% occurrence of atrial fibrillation. Patients with only 1 of these characteristics were at intermediate risk (20%), and those with neither characteristic were at lowest risk (10%). The determinants and clinical course of atrial fibrillation did not differ between an early (< or = 1 month) compared with a later onset. Atrial fibrillation was persistent and recurrent, requiring long-term therapy in 18 patients, including 12 of 19 (63%) with prior atrial fibrillation and left ventricular dysfunction.
Atrial fibrillation after type I flutter ablation is primarily determined by the presence of a preexisting structural and electrophysiological substrate. These data should be considered in planning postablation management. The persistent risk of atrial fibrillation in this population also suggests a potentially important role for atrial fibrillation as a trigger rather than a consequence of type I atrial flutter.
I型心房扑动消融术后房颤的发生仍然是一个重要的临床问题。为了进一步深入了解消融术后房颤的发病机制和意义,我们在一个大型患者队列中研究了I型扑动消融术后房颤的发作时间、决定因素和临床病程。
在110例连续接受I型心房扑动消融术的患者中,平均随访20.1±9.2个月期间,有28例(25%)记录到房颤(1个月时累积发生率为12%,1年时为23%,2年时为30%)。在17个临床和手术变量中,只有自发房颤病史(相对风险3.9,95%可信区间1.8至8.8,P = 0.001)和左心室射血分数<50%(相对风险3.8,95%可信区间1.7至8.5,P = 0.001)是后续房颤的显著且独立预测因素。这两个特征同时存在可确定一个高危组,房颤发生率为74%。仅具有其中一个特征的患者处于中度风险(20%),而两者均不具备的患者风险最低(10%)。房颤的决定因素和临床病程在早期(≤1个月)发作与晚期发作之间并无差异。房颤呈持续性和复发性,18例患者需要长期治疗,其中19例(63%)有既往房颤和左心室功能障碍的患者中有12例。
I型扑动消融术后房颤主要由先前存在的结构和电生理基质决定。在规划消融术后管理时应考虑这些数据。该人群中房颤的持续风险也提示房颤作为I型心房扑动的触发因素而非结果可能具有潜在重要作用。